News
Latest news from CHV and our portfolio companies
Featured News
Acquisition expands Gore’s cardiac portfolio through a high-growth adjacency CAUTION: Investigational Device. Limited by federal (or United States) law to investigational use. Outside the United States, the device is intended…
Insights & Impacts: The latest from CHV
Seasoned Medical Device Executive, James Reinstein, Appointed as Chief Executive Officer Conformal Medical, Inc., a
– Grant Supports Continued Clinical Development of the Company’s PTM-101 Product and its Potential for
BEDFORD, Mass., – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral
Study to support U.S. FDA approval of the novel CLAASâ implant for left atrial appendage
– Patent Validates Novelty and Breadth of Proprietary Sagittari™ Treatment Platform and Expands Potential for
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health
The brain (put way too simply) is a complicated organ that remains hard to fully
Project focused on reducing maternal and neonatal mortality and morbidity by mitigating risks associated with
AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health